Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Lyophilised peptides are inherently stable in their dry state, but once reconstituted they become susceptible to microbial contamination and degradation
Adaptive responses to hypoxia and/or hyperoxia in humans
1.21.29
because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
US$ 23.62
US$ 25.56
US$ 21.76
US$ 21.06
